MEDI Among Health Care ETFs
End-of-day Nov 20, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.6% | −6.7% | +0.1% | −2.5% | +7.8% | +7.7% | +56.1% | — | — | +76.6% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$211 of every $1,000 in MEDI is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 21.06% | $2,106.13 | 6,409 | $8.7M |
| 2 | —Ascendis Pharma A/S | — | 16.53% | $1,652.56 | 27K | $6.8M |
| 3 | ARGNFArgenx SE | — | 5.13% | $512.78 | 2,238 | $2.1M |
| 4 | INSMInsmed | Healthcare | 3.68% | $368.40 | 10K | $1.5M |
| 5 | GHGuardant Health | Healthcare | 3.53% | $352.51 | 9,955 | $1.4M |
| 6 | UTHRUnited Therapeutics | Healthcare | 3.42% | $341.73 | 2,513 | $1.4M |
| 7 | PCVXVaxcyte | Healthcare | 3.28% | $327.93 | 23K | $1.3M |
| 8 | RYTMRhythm Pharmaceuticals | Healthcare | 3.18% | $318.17 | 11K | $1.3M |
| 9 | IDXXIdexx Laboratories | Healthcare | 2.62% | $261.50 | 1,559 | $1.1M |
| 10 | RVMDRevolution Medicines | Healthcare | 2.56% | $255.97 | 6,601 | $1.1M |
| 11 | CORCencora | Healthcare | 2.22% | $222.44 | 2,680 | $915K |
| 12 | NTRANatera | Healthcare | 2.02% | $202.02 | 2,865 | $831K |
| 13 | SUPNSupernus | Healthcare | 1.73% | $172.60 | 25K | $710K |
| 14 | UNHUnitedhealth Group | Healthcare | 1.69% | $168.88 | 2,101 | $694K |
| 15 | ABBVAbbvie | Healthcare | 1.64% | $163.51 | 2,371 | $672K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 21.06% |
| 2 | ARGNF | Argenx SE - | 5.13% |
| 3 | INSM | Insmed | 3.68% |
| 4 | GH | Guardant Health | 3.53% |
| 5 | UTHR | United Therapeutics | 3.42% |
| 6 | PCVX | Vaxcyte | 3.28% |
| 7 | RYTM | Rhythm Pharmaceuticals | 3.18% |
| 8 | IDXX | Idexx Laboratories | 2.62% |
| 9 | RVMD | Revolution Medicines | 2.56% |
| 10 | COR | Cencora | 2.22% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2025 | Dec 24, 2025 | $0.0751 |
| Dec 20, 2024 | Dec 26, 2024 | $0.13 |
| Dec 21, 2023 | Dec 27, 2023 | $0.46 |